BRIAN BORA: Open Payments
NPI 1891892600 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,901 in 119 payments from 12 companies in 2025. Trend: 2023 $2,860 · 2024 $3,819 · 2025 $3,901
Food & beverage: $3,895Education: $5
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $610 |
| Janssen Pharmaceuticals, Inc | 15 | $578 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $470 |
| ABBVIE INC. | 18 | $446 |
| Axsome Therapeutics, Inc. | 8 | $362 |
| E.R. Squibb & Sons, L.L.C. | 9 | $356 |
| Alkermes, Inc. | 10 | $339 |
| Neurocrine BioSciences, Inc. | 6 | $255 |
| Otsuka America Pharmaceutical, Inc. | 9 | $189 |
| Teva Pharmaceuticals USA, Inc. | 7 | $153 |
Products named: FANAPT, CAPLYTA, VRAYLAR, Auvelity, COBENFY, SPRAVATO, INGREZZA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
